An oversubscribed $37M Series B for happier, healthier pets?! 🐶 🐱 Join us at Edventure Emerge to hear from the brilliant @JolyonMartin about how he’s using current edge science to take better care of our pets. Don’t miss out, get your tickets now: https://t.co/htqmEwJ20D 🎟
#PRESS: Proud to announce we have partnered with @PetMedix 🙏! Our aim? To develop novel and transformative #antibody therapeutics for #pets - together: ➡️ https://t.co/9uwZynxvy7 #AnimalHealth
In this month's issue, @JolyonMartin co-founder of @PetMedix, and @johnfinnes co-founder of @veterinarytbank and Chair of @theRCVS Fellowship Board, discuss the implications of advances in the field of monoclonal antibodies in the veterinary health market
https://t.co/ClzZ6JIISH
Great to be in KC with Tom, showing off the great science and opportunity that PetMedix represents to a new audience. If you’re here today, come say hi. #KCAnimalHealth#startup#pitching#animalhealth
Looking forward to discussing how we can bring the latest human therapies to animal health on a panel chaired by Mark Heffernan of Stonehaven Incubate.